Literature DB >> 15750216

Insulin signaling, diabetes mellitus and risk of Alzheimer disease.

Xiongwei Zhu1, George Perry, Mark A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15750216     DOI： 10.3233/jad-2005-7108

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


× No keyword cloud information.
  12 in total

Review 1.  MicroRNAs in brain development and degeneration.

Authors:  Ana-Maria Enciu; Bogdan Ovidiu Popescu; Ancuta Gheorghisan-Galateanu
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

2.  Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.

Authors:  Ying Liu; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Pathol       Date:  2011-05-19       Impact factor: 7.996

3.  Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model.

Authors:  Xu Wang; Wei Zheng; Jing-Wei Xie; Tao Wang; Si-Ling Wang; Wei-Ping Teng; Zhan-You Wang
Journal:  Mol Neurodegener       Date:  2010-11-02       Impact factor: 14.195

4.  Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.

Authors:  Ying Liu; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2009-07-31       Impact factor: 5.372

5.  Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.

Authors:  Yanqiu Deng; Bin Li; Ying Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

6.  Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; John M Hayes; Eva L Feldman
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

Review 7.  Linking insulin with Alzheimer's disease: emergence as type III diabetes.

Authors:  Sara Ahmed; Zahra Mahmood; Saadia Zahid
Journal:  Neurol Sci       Date:  2015-08-07       Impact factor: 3.307

Review 8.  [Diabetes mellitus and cognitive decline].

Authors:  Bernhard Iglseder
Journal:  Wien Med Wochenschr       Date:  2011-07-29

Review 9.  Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.

Authors:  Alexander O Shpakov; Kira V Derkach; Lev M Berstein
Journal:  Future Sci OA       Date:  2015-11-01

Review 10.  The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain.

Authors:  Choon Sang Bae; Juhyun Song
Journal:  Int J Mol Sci       Date:  2017-11-22       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.